Questions? We are here to help.

(833) 965-2070

Free Claim Review

100% Confidential


  • Free Consultation: Start with a no-obligation consultation to discuss your case and understand your options.
  • Comprehensive Case Evaluation: We thoroughly review the details of your case to build a strong claim on your behalf.
  • Aggressive Representation: We will fight tirelessly for the just compensation you’re due.

No up-front costs and no fees whatsoever unless you win

By filling out the form above, I agree to receive telephone calls and text messages at the telephone number provided above/below (including any mobile number provided) to our law firm. I understand that consent to receiving phone calls and/or text is not a condition to the formation of an attorney-client relationship. I also have read and agree to your Disclaimer and Privacy Policy.

THIS IS ATTORNEY ADVERTISING 

sponsored by 

Clancy Fleishman Law

located at

40 Wall Street 25th Floor New York, NY 10005

Dupixent & Cancer Lawsuits

We Are Attorneys Who Will Fight For You

Were  you diagnosed with Cutaneous T-cell Lymphoma (CTCL),  Mycosis fungoides, or Sezary syndrome, after taking the biologic medication Dupixent?

Fill out the form and get a free case evaluation today!

Call Now (855) 589-4512

Wendy Fleishman and Donna Clancy: Fierce Advocates for Justice and Accountability

Who May Qualify for a Claim

We stand with vicitims and fight to hold companies  accountable. We pursue justice with compassion, discretion, and relentless advocacy. Your voice matters—and we are here to help you be heard.

Investigating Potential Links to 
Lymphoma and Cutaneous T-Cell 
Lymphoma (CTCL)

Wendy R. Fleishman

Donna Clancy

Donna Clancy

You may be eligible to pursue a claim if the following apply:

  • You used Dupixent (dupilumab) injections continuously for at least 6 months, and
  • You were prescribed Dupixent to treat one of the following conditions:
    • Eczema (atopic dermatitis)
    • Asthma
    • Chronic rhinosinusitis with nasal polyps
    • Eosinophilic esophagitis (EoE)
    • Chronic obstructive pulmonary disease (COPD)
    • Mycosis fungoides
    • Sézary syndrome
  • After starting Dupixent treatment, you were diagnosed with:
    • Lymphoma, or
    • Malignant Cutaneous T-Cell Lymphoma (CTCL)
  • Your diagnosis occurred typically more than one year after beginning Dupixent, and
  • You experienced warning signs such as:
    • A persistent or spreading rash that did not improve
    • New or worsening skin nodules
    • Swollen lymph nodes
  • You are not currently represented by another law firm for this specific claim

Who May Qualify for a Dupixent Lawsuit?